Institutional investors hold a majority ownership of ABBV through the 80.59% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2014, these large investors purchased a net $143.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 24.0 Million shares of AbbVie
OZ MANAGEMENT LP Bought 15.3 Million shares of AbbVie
PAULSON & CO., INC. Bought 13.0 Million shares of AbbVie